Io Biotech Stock Technical Analysis
| IOBT Stock | USD 0.36 0.01 3.57% |
As of the 11th of February 2026, IO Biotech owns the Semi Deviation of 12.35, standard deviation of 19.44, and Market Risk Adjusted Performance of (8.65). IO Biotech technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.
IO Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as IOBT, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IOBTIO Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.IO Biotech Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 2.18 | Strong Buy | 5 | Odds |
Most IOBT analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand IOBT stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of IO Biotech, talking to its executives and customers, or listening to IOBT conference calls.
Is there potential for Biotechnology market expansion? Will IOBT introduce new products? Factors like these will boost the valuation of IO Biotech. Market participants price IOBT higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about IO Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
IO Biotech's market price often diverges from its book value, the accounting figure shown on IOBT's balance sheet. Smart investors calculate IO Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since IO Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IO Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if IO Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IO Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IO Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IO Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IO Biotech.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in IO Biotech on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding IO Biotech or generate 0.0% return on investment in IO Biotech over 90 days. IO Biotech is related to or competes with Werewolf Therapeutics, Spruce Biosciences, Adicet Bio, OUTLOOK THERAPEUTICS, Cue Biopharma, Karyopharm Therapeutics, and NRX Pharmaceuticals. IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T... More
IO Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IO Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IO Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 13.4 | |||
| Information Ratio | 0.0047 | |||
| Maximum Drawdown | 151.49 | |||
| Value At Risk | (16.22) | |||
| Potential Upside | 13.33 |
IO Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IO Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IO Biotech's standard deviation. In reality, there are many statistical measures that can use IO Biotech historical prices to predict the future IO Biotech's volatility.| Risk Adjusted Performance | 0.0171 | |||
| Jensen Alpha | 0.1749 | |||
| Total Risk Alpha | (1.83) | |||
| Sortino Ratio | 0.0068 | |||
| Treynor Ratio | (8.66) |
IO Biotech February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0171 | |||
| Market Risk Adjusted Performance | (8.65) | |||
| Mean Deviation | 8.98 | |||
| Semi Deviation | 12.35 | |||
| Downside Deviation | 13.4 | |||
| Coefficient Of Variation | 10608.58 | |||
| Standard Deviation | 19.44 | |||
| Variance | 377.73 | |||
| Information Ratio | 0.0047 | |||
| Jensen Alpha | 0.1749 | |||
| Total Risk Alpha | (1.83) | |||
| Sortino Ratio | 0.0068 | |||
| Treynor Ratio | (8.66) | |||
| Maximum Drawdown | 151.49 | |||
| Value At Risk | (16.22) | |||
| Potential Upside | 13.33 | |||
| Downside Variance | 179.56 | |||
| Semi Variance | 152.44 | |||
| Expected Short fall | (12.04) | |||
| Skewness | 4.09 | |||
| Kurtosis | 30.65 |
IO Biotech Backtested Returns
IO Biotech appears to be out of control, given 3 months investment horizon. IO Biotech retains Efficiency (Sharpe Ratio) of 0.0171, which attests that the entity had a 0.0171 % return per unit of price deviation over the last 3 months. We have found twenty-six technical indicators for IO Biotech, which you can use to evaluate the volatility of the firm. Please utilize IO Biotech's Standard Deviation of 19.44, market risk adjusted performance of (8.65), and Semi Deviation of 12.35 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, IO Biotech holds a performance score of 1. The company owns a Beta (Systematic Risk) of -0.02, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning IO Biotech are expected to decrease at a much lower rate. During the bear market, IO Biotech is likely to outperform the market. Please check IO Biotech's information ratio and the relationship between the maximum drawdown and day typical price , to make a quick decision on whether IO Biotech's current price history will revert.
Auto-correlation | 0.26 |
Poor predictability
IO Biotech has poor predictability. Overlapping area represents the amount of predictability between IO Biotech time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IO Biotech price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current IO Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
IO Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
IO Biotech Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for IO Biotech across different markets.
About IO Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of IO Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of IO Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on IO Biotech price pattern first instead of the macroeconomic environment surrounding IO Biotech. By analyzing IO Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of IO Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to IO Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
IO Biotech February 11, 2026 Technical Indicators
Most technical analysis of IOBT help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IOBT from various momentum indicators to cycle indicators. When you analyze IOBT charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0171 | |||
| Market Risk Adjusted Performance | (8.65) | |||
| Mean Deviation | 8.98 | |||
| Semi Deviation | 12.35 | |||
| Downside Deviation | 13.4 | |||
| Coefficient Of Variation | 10608.58 | |||
| Standard Deviation | 19.44 | |||
| Variance | 377.73 | |||
| Information Ratio | 0.0047 | |||
| Jensen Alpha | 0.1749 | |||
| Total Risk Alpha | (1.83) | |||
| Sortino Ratio | 0.0068 | |||
| Treynor Ratio | (8.66) | |||
| Maximum Drawdown | 151.49 | |||
| Value At Risk | (16.22) | |||
| Potential Upside | 13.33 | |||
| Downside Variance | 179.56 | |||
| Semi Variance | 152.44 | |||
| Expected Short fall | (12.04) | |||
| Skewness | 4.09 | |||
| Kurtosis | 30.65 |
IO Biotech February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as IOBT stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 0.36 | ||
| Day Typical Price | 0.36 | ||
| Price Action Indicator | (0.01) |
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.